Santen CEO joins Glaucoma Research Foundation

Article

Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation?s board of directors.

Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation’s board of directors.

Prior to joining Santen in 1995, Graves worked with Alcon Labs having studied visual psychophysics and electrophysiology.

“Having observed the quality of Dr Graves’ work as a scientist and CEO, I feel she brings tremendous energy, experience and qualifications to the board,” said Dr Kuldev Singh, chair of the Glaucoma Research Foundation.

Graves co-founded Ophthalmic Women Leaders with Dr Marguerite McDonald and is on the boards of the American Academy of Ophthalmology Foundation, the Pan-American Ophthalmological Foundation and the corporation committee for the Brown University Medical School.

Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.